|
NIG-RNAi Strains Detail |
Request : Click the "Order" button to request for this stock |
|
Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
Stock ID |
1212R-3 |
Symbol |
p130CAS |
Full Name |
p130CAS |
CG No |
CG1212 |
Old CG No |
CG1212 |
Synonyms |
CG1212, CT1293, p130CAS |
Accession No (Link to NCBI) |
NM_138158.2 |
Inserted Chr. |
lll |
Insertional Mutation |
|
Phenotype induced by Act5C-GAL4 at 28 degrees |
viable |
Map Viewer |
|
Reference
[Please submit your publication]
|
Park SH, Lee CW, Lee JH, Park JY, Roshandell M, Brennan CA, Choe KM. Requirement for and polarized localization of integrin proteins during Drosophila wound closure. Mol Biol Cell (2018) 29(18) 2137-2147
[
PubMed ID = 29995573
]
[
RRC reference
]
Dourlen P, Fernandez-Gomez FJ, Dupont C, Grenier-Boley B, Bellenguez C, Obriot H, Caillierez R, Sottejeau Y, Chapuis J, Bretteville A, Abdelfettah F, Delay C, Malmanche N, Soininen H, Hiltunen M, Galas MC, Amouyel P, Sergeant N, Buée L, Lambert JC, Dermaut B. Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology. Mol Psychiatry (2017) 22(6) 874-883
[
PubMed ID = 27113998
]
[
RRC reference
]
|
Comment |
|
Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
Primer Seq. 5' |
aaggcctacatggccggaccgGAGAACGGTTCCGTCATCAGT |
Primer Seq. 3' |
aatctagaggtaccAAGATCAGGGGTCGTGGCACA |
Predicted Fragment Size |
500 |
IR fragment full Seq |
0001 NAGAACGGTT CCGTCATCAG TGCGGTATCG TCCTCAAACT CAAATTCGGG AGGGGCTAGT
0061 AGTGGACTCG GATCGGAGTC GGTGTCTCGT GTCTCGAGGA GATCGTGGCA CGCCTCGCCG
0121 ACAAAGGTAA TCACACCACA GCGACACGGT GATGTATACA TCTACAATTA CTCGCCAGGA
0181 TCAGCGACTG GATCTGGAGC AAGAGCCGCG CCCAGNACGC CGCAGCAGCA GATCTATAGC
0241 AACCAAAGCA TCTACCAGAA CTTTGCAATG ATGTCCAGTC CTCGCCAAAA CGCAAGTGGC
0301 NAGCGAGTTT GAGACCTATG ACATACCCAA GCCGGCCACG CCCGTTCCGC TGAACTACGA
0361 CAGTCCCAGA AGCGGTCTTC CGAAGGCTTC TAACTCTACA ACGACCTCCA GCTCCAGCCT
0421 AGGCACCCGG TTTGAGACAC TCAAGAGCGT GGCCGCATCC ATTGCGGAGG AGTCTTACGA
0481 TGTGCCACGA CCCCTGATCT T |
in silico PCR Fragment |
0001 GAGAACGGTT CCGTCATCAG TGCGGTATCG TCCTCAAACT CAAATTCGGG AGGGGCTAGT
0061 AGTGGACTCG GATCGGAGTC GGTGTCTCGT GTCTCGAGGA GATCGTGGCA CGCCTCGCCG
0121 ACAAAGGTAA TCACACCACA GCGACACGGT GATGTATACA TCTACAATTA CTCGCCAGGA
0181 TCAGCGACTG GATCTGGAGC AAGAGCCGCG CCCAGCACGC CGCAGCAGCA GATCTATAGC
0241 AACCAAAGCA TCTACCAGAA CTTTGCAATG ATGTCCAGTC CTCGCCAAAA CGCAAGTGGC
0301 -AGCGAGTTT GAGACCTATG ACATACCCAA GCCGGCCACG CCCGTTCCGC TGAACTACGA
0361 CAGTCCCAGA AGCGGTCTTC CGAAGGCTTC TAACTCTACA ACGACCTCCA GCTCCAGCCT
0421 AGGCACCCGG TTTGAGACAC TCAAGAGCGT GGCCGCATCC ATTGCGGAGG AGTCTTACGA
0481 TGTGCCACGA CCCCTGATCT T |
Assemble Data |
1212R-3.IR_full 1 AGAACGGTTCCGTCATCAGTGCGGTATCGTCCTCAAACTCAAATTCGGGAGGGGCTAGT 59
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1212R-3.in silico 1 AGAACGGTTCCGTCATCAGTGCGGTATCGTCCTCAAACTCAAATTCGGGAGGGGCTAGT 59
1212R-3.IR_full 61 AGTGGACTCGGATCGGAGTCGGTGTCTCGTGTCTCGAGGAGATCGTGGCACGCCTCGCCG 119
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1212R-3.in silico 61 AGTGGACTCGGATCGGAGTCGGTGTCTCGTGTCTCGAGGAGATCGTGGCACGCCTCGCCG 119
1212R-3.IR_full 121 ACAAAGGTAATCACACCACAGCGACACGGTGATGTATACATCTACAATTACTCGCCAGGA 179
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1212R-3.in silico 121 ACAAAGGTAATCACACCACAGCGACACGGTGATGTATACATCTACAATTACTCGCCAGGA 179
1212R-3.IR_full 181 TCAGCGACTGGATCTGGAGCAAGAGCCGCGCCCAGNACGCCGCAGCAGCAGATCTATAGC 239
||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||||
1212R-3.in silico 181 TCAGCGACTGGATCTGGAGCAAGAGCCGCGCCCAGCACGCCGCAGCAGCAGATCTATAGC 239
1212R-3.IR_full 241 AACCAAAGCATCTACCAGAACTTTGCAATGATGTCCAGTCCTCGCCAAAACGCAAGTGGC 299
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1212R-3.in silico 241 AACCAAAGCATCTACCAGAACTTTGCAATGATGTCCAGTCCTCGCCAAAACGCAAGTGGC 299
1212R-3.IR_full 301 AGCGAGTTTGAGACCTATGACATACCCAAGCCGGCCACGCCCGTTCCGCTGAACTACGA 358
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1212R-3.in silico 301 AGCGAGTTTGAGACCTATGACATACCCAAGCCGGCCACGCCCGTTCCGCTGAACTACGA 358
1212R-3.IR_full 361 CAGTCCCAGAAGCGGTCTTCCGAAGGCTTCTAACTCTACAACGACCTCCAGCTCCAGCCT 418
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1212R-3.in silico 361 CAGTCCCAGAAGCGGTCTTCCGAAGGCTTCTAACTCTACAACGACCTCCAGCTCCAGCCT 418
1212R-3.IR_full 421 AGGCACCCGGTTTGAGACACTCAAGAGCGTGGCCGCATCCATTGCGGAGGAGTCTTACGA 478
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1212R-3.in silico 421 AGGCACCCGGTTTGAGACACTCAAGAGCGTGGCCGCATCCATTGCGGAGGAGTCTTACGA 478
1212R-3.IR_full 481 TGTGCCACGACCCCTGATCTT 499
|||||||||||||||||||||
1212R-3.in silico 481 TGTGCCACGACCCCTGATCTT 499
|
Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
0 |
0 |
0 |
NM_138158.2 |
CG1212-RA, transcript variant A (p130CAS), mRNA |
73.85 |
356 |
1 |
1 |
1 |
NM_167797.1 |
CG1212-RB, transcript variant B (p130CAS), mRNA |
0 |
0 |
2 |
8 |
3 |
NM_141889.2 |
CG3169-RA (Spt3), mRNA |
0 |
0 |
1 |
4 |
7 |
NM_137664.1 |
CG9025-RA, transcript variant A (CG9025), mRNA |
0 |
0 |
1 |
4 |
5 |
NM_166408.1 |
CG9025-RB, transcript variant B (CG9025), mRNA |
0 |
0 |
1 |
3 |
4 |
NM_142880.2 |
CG13827-RA (CG13827), mRNA |
0 |
0 |
1 |
3 |
3 |
NM_078569.2 |
CG1554-RA (RpII215), mRNA |
0 |
0 |
1 |
3 |
2 |
NM_132420.2 |
CG32676-RA (CG32676), mRNA |
0 |
0 |
1 |
2 |
7 |
NM_057858.3 |
CG9985-RA (sktl), mRNA |
0 |
0 |
1 |
2 |
6 |
NM_166341.1 |
CG30127-RA (CG30127), mRNA |
0 |
0 |
1 |
2 |
5 |
NM_079282.1 |
CG3322-RA (LanB2), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_169223.2 |
CG31369-RA (PQBP-1), mRNA |
0 |
0 |
0 |
5 |
23 |
NM_136257.2 |
CG8677-RA (CG8677), mRNA |
0 |
0 |
0 |
5 |
19 |
NM_165362.1 |
CG31626-RA, transcript variant A (CG31626), mRNA |
0 |
0 |
0 |
5 |
19 |
NM_165363.1 |
CG31626-RB, transcript variant B (CG31626), mRNA |
0 |
0 |
0 |
5 |
4 |
NM_136237.2 |
CG9265-RA (CG9265), mRNA |
0 |
0 |
0 |
4 |
7 |
NM_078717.2 |
CG3696-RA, transcript variant A (kis), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_001014518.1 |
CG2368-RK, transcript variant K (psq), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_206086.1 |
CG2368-RC, transcript variant C (psq), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_176143.1 |
CG2368-RH, transcript variant H (psq), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_165790.1 |
CG2368-RA, transcript variant A (psq), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_165791.1 |
CG2368-RD, transcript variant D (psq), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_001014519.1 |
CG2368-RJ, transcript variant J (psq), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_165792.1 |
CG2368-RE, transcript variant E (psq), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_176142.1 |
CG2368-RG, transcript variant G (psq), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_001014517.1 |
CG2368-RL, transcript variant L (psq), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_001014520.1 |
CG2368-RI, transcript variant I (psq), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_078962.2 |
CG2368-RB, transcript variant B (psq), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_176141.1 |
CG2368-RF, transcript variant F (psq), mRNA |
0 |
0 |
0 |
4 |
6 |
NM_136553.2 |
CG8639-RA (Cirl), mRNA |
|
|
|